Polyphosphate amplifies proinflammatory responses of nuclear proteins through interaction with receptor for advanced glycation end products and P2Y1 purinergic receptor

Blood

Volumn 123, Issue 6, 2014, Pages 935-945

  Dinarvand, Peyman ^a   Hassanian, Seyed Mahdi ^a   Qureshi, Shabir H ^a   Manithody, Chandrashekhara ^a   Eissenberg, Joel C ^a   Yang, Likui ^a   Rezaie, Alireza R ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ADVANCED GLYCATION END PRODUCT RECEPTOR; ANTICOAGULANT AGENT; CALCIUM ION; CASPASE 8; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH MOBILITY GROUP B1 PROTEIN; HISTONE H4; INTERCELLULAR ADHESION MOLECULE 1; POLYPHOSPHATE; PURINERGIC P2Y1 RECEPTOR; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; VASCULAR CELL ADHESION MOLECULE 1; ADVANCED GLYCATION END PRODUCT; AUTACOID; CALCIUM; HISTONE; HMGB1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; MOK PROTEIN, HUMAN; PROTEIN C; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TUMOR ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; ASTROCYTE; BACTERIAL INFECTION; BLOOD CLOTTING; CALCIUM TRANSPORT; CELL MEMBRANE PERMEABILITY; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOKINE RESPONSE; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE MIGRATION; MALE; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; SEPSIS; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; C57BL MOUSE; CELL MOTION; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM;

ANIMALS; ANTIGENS, NEOPLASM; CALCIUM; CELL MEMBRANE PERMEABILITY; CELL MOVEMENT; GLYCOSYLATION END PRODUCTS, ADVANCED; HISTONES; HMGB1 PROTEIN; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; POLYPHOSPHATES; PROTEIN C; RECEPTORS, PURINERGIC P2Y1; RNA, SMALL INTERFERING; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84894036111     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-09-529602     Document Type: Article

References (30)

1. Xu J, Zhang X, Pelayo R, et al. Extracellular histones are major mediators of death in sepsis. Nat Med. 2009;15(11):1318-1321.
2. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285(5425):248-251. (Pubitemid 29329996)
3. Sama AE, D'Amore J, Ward MF, Chen G, Wang H. Bench to bedside: HMGB1-a novel proinflammatory cytokine and potential therapeutic target for septic patients in the emergency department. Acad Emerg Med. 2004;11(8):867-873. (Pubitemid 38960684)
4. DeMarco RA, Fink MP, Lotze MT. Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1. Mol Immunol. 2005;42(4):433-444. (Pubitemid 39655950)
5. Fuchs TA, Brill A, Duerschmied D, et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA. 2010;107(36):15880-15885.
6. Holdenrieder S, Nagel D, Schalhorn A, et al. Clinical relevance of circulating nucleosomes in cancer. Ann N Y Acad Sci. 2008;1137:180-189.
7. Fritz G. RAGE: a single receptor fits multiple ligands. Trends Biochem Sci. 2011;36(12):625-632.
8. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol. 2005;5(4):331-342. (Pubitemid 40516158)
9. Fiuza C, Bustin M, Talwar S, et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood. 2003;101(7):2652-2660. (Pubitemid 36857626)
10. Esmon CT. Molecular circuits in thrombosis and inflammation. Thromb Haemost. 2013;109(3):416-420.
11. Cohen J. The immunopathogenesis of sepsis. Nature. 2002;420(6917):885- 891. (Pubitemid 36019643)
12. Beutler B, Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol. 2003;3(2):169-176. (Pubitemid 37328694)
13. Bae JS, Rezaie AR. Activated protein C inhibits high mobility group box 1 signaling in endothelial cells. Blood. 2011;118(14):3952-3959.
14. Morrissey JH, Choi SH, Smith SA. Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation. Blood. 2012;119(25):5972-5979.
15. Maugeri N, Franchini S, Campana L, et al. Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis. Autoimmunity. 2012;45(8):584-587.
16. Semeraro F, Ammollo CT, Morrissey JH, et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood. 2011;118(7):1952-1961.
17. Bae JS, Lee W, Rezaie AR. Polyphosphate elicits pro-inflammatory responses that are counteracted by activated protein C in both cellular and animal models. J Thromb Haemost. 2012;10(6):1145-1151.
18. Holmström KM, Marina N, Baev AY, Wood NW, Gourine AV, Abramov AY. Signalling properties of inorganic polyphosphate in the mammalian brain. Nat Commun. 2013;4:1362.
19. Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science. 2002;296(5574):1880-1882. (Pubitemid 34596276)
20. Mosnier LO, Zlokovic BV, Griffin JH. The cytoprotective protein C pathway. Blood. 2007;109(8):3161-3172. (Pubitemid 46572500)
21. Kerschen EJ, Fernandez JA, Cooley BC, et al. Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. J Exp Med. 2007;204(10):2439-2448. (Pubitemid 47529328)
22. Kornberg A, Rao NN, Ault-Riché D. Inorganic polyphosphate: a molecule of many functions. Annu Rev Biochem. 1999;68:89-125. (Pubitemid 29449188)
23. Liliensiek B, Weigand MA, Bierhaus A, et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest. 2004;113(11):1641-1650. (Pubitemid 39071688)
24. Bierhaus A, Humpert PM, Morcos M, et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl). 2005;83(11):876-886. (Pubitemid 41598688)
25. Ramasamy R, Yan SF, Schmidt AM. RAGE: therapeutic target and biomarker of the inflammatory response-the evidence mounts. J Leukoc Biol. 2009;86(3):505-512.
26. Bernard GR, Vincent JL, Laterre PF, et al; Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344(10):699-709.
27. Kalil AC, LaRosa SP. Effectiveness and safety of drotrecogin alfa (activated) for severe sepsis: a meta-analysis and metaregression. Lancet Infect Dis. 2012;12(9):678-686.
28. Rezaie AR. Regulation of the protein C anticoagulant and antiinflammatory pathways. Curr Med Chem. 2010;17(19):2059-2069.
29. Tian J, Avalos AM, Mao S-Y, et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol. 2007;8(5):487-496. (Pubitemid 46605917)
30. Huang H, Evankovich J, Yan W, et al. Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice. Hepatology. 2011;54(3):999-1008.